Subscribe To
Takeda provides update on tak-994 clinical program
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that a safe...
October 5, 2021, 7:33 pm
Takeda provides update on tak-994 clinical program
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that a safe...
October 5, 2021, 7:33 pm
Takeda provides update on tak-994 clinical program
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that a safe...
October 5, 2021, 7:33 pm
Takeda provides update on tak-994 clinical program
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that a safe...
October 5, 2021, 7:33 pm